Aptar Digital to use AstraZeneca’s AI algorithms for CKD detection
Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting CKD using the latter’s AI-driven screening algorithms.
Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting CKD using the latter’s AI-driven screening algorithms.
What's Your Reaction?
